Multiply Labs, a specialist in robotic biomanufacturing, has announced what it describes as a “landmark milestone” in its mission to scale production of cell and gene therapies.
The company is now leveraging Nvidia’s open Isaac and GR00T technologies, including advanced robotics simulation and perception, marking a turning point for an industry that has historically relied on manual, “artisanal” processes.
Cell and gene therapies are life-changing treatments that hold the potential to address cancer and autoimmune diseases, but manufacturing remains difficult to scale with time-intensive processes and variability that can impact throughput and cost. [Read more…] about Multiply Labs partners with Nvidia to bring physical AI robotics to advanced biomanufacturing